H3D Vision & Mission
Vision: To be the leading organisation for integrated drug discovery and development on the African continent Mission: Discover and develop innovative, life saving medicines For African patients Through excellence in interdisciplinary,...
H3D Facilities
Facilities H3D has state of the art laboratory equipment and access to modern instrumentation housed in the Department of Chemistry, the Department of Clinical Pharmacology and the Institute of Infectious Disease and Molecular Medicine (IDM) at UCT...
R&D Environment
UCT offers a truly integrated environment for translational research in communicable and non communicable diseases afflicting people in Africa. It has both the infrastructure as well as numerous groups working on pre-clinical and clinical research...
Home > Home


Sunday, 18 April 2021
Dr. Kelly Chibale presents at the Isdell:Flowers Cross Border Malaria Initiative's 2020 Round Table in Livingstone, Zambia
Sights Set on Malaria Eradication: Traditional and Religious Leaders Convene with National Governments, Leading Scientists, and Communities Affected by Malaria at 2020 Isdell:Flowers Round Table

Kelly Chibale, Founder and Director of H3D and Neville Isdell Chair, and Nina Lawrence, Senior Investigator, presented at the J.C. Flowers Foundation’s Isdell:Flowers Cross Border Malaria Initiative’s 2020 Round Table on February 27th and 28th in Livingstone, Zambia. The duo, who spoke on a panel discussing scientific highlights in the field of malaria elimination, described the importance of developing new medicines for malaria elimination and eradication with an African-centric design.

Publication Date:
Mon, 30 Mar 2020 - 09:45
Second H3D-SHAWCO Health Collaborative Event – March 2020


UCT’s Drug Discovery and Development Centre (H3D) aims to bring new medicines “from the bench to the bedside”. But how acquainted are prospective healthcare professionals with the difficulties of developing new treatments? Conversely, are research scientists aware of the challenges faced by medical professionals at the frontline of public healthcare in South Africa? These were the questions that the second collaboration between H3D and SHAWCO Health, UCT’s student-run community outreach organisation, sought to address.


Publication Date:
Fri, 20 Mar 2020 - 09:45
H3D honours Neville Isdell for his generosity and leadership



Recently, H3D hosted a lunch in honour of Mr Neville Isdell to thank him for his generosity and leadership. Mr Isdell donated approximately R18 million towards the establishment of a five-year Neville Isdell Chair in African-centric Drug Discovery and Development at H3D. 


Publication Date:
Mon, 09 Mar 2020 - 09:45
The Time is Now for Antimicrobial Research and Development in Africa

Antimicrobial resistance (AMR) has been an ongoing threat to public health in South Africa as well as other countries in Africa. Disturbingly, the burden in the continent from infectious diseases has also been on the rise. Part of the reason is the persistence of infections associated with tropical regions as well as the higher rates of poverty and greater spread of drug resistance. 

Publication Date:
Fri, 06 Dec 2019 - 11:00